keyboard_arrow_upPollution liability risk on the rise for SA businesses
keyboard_arrow_downPollution liability risk on the rise for SA businesses

Pollution liability is becoming an increasingly intricate issue in South Africa and businesses, as well as the relevant directors and employees in their personal capacity, are facing an increased risk of being held criminally and civilly liable for causing damage to the environment. A person or business who pollutes the environment if found guilty can be liable on conviction to a fine of up to R5 million or to imprisonment for a period not exceeding five years.

keyboard_arrow_upRevised standards to improve medicinal product description
keyboard_arrow_downRevised standards to improve medicinal product description

A series of Identification of Medicinal Products (IDMP) standards are under revision and will bring a host of benefits to patients and the global health care community.

keyboard_arrow_upInnovation and compliance converge on UL’s Prospector
keyboard_arrow_downInnovation and compliance converge on UL’s Prospector

It is crucial for formulators to remain abreast of global regulatory changes. The latest developments on Prospector, the materials and ingredients search engine from UL, provide the personal care industry with an overview of global regulatory information.

keyboard_arrow_upSetting the quality standards
keyboard_arrow_downSetting the quality standards

A quality system is crucial in the manufacturing of cosmetics to maximise product quality outcomes and maintain compliance, be it with local or international regulations. The essence of this is outlined in a white paper by John Garvey, CEO of Compliance Architects.

keyboard_arrow_upUnderstanding the EU Cosmetics Regulation and attaining compliance
keyboard_arrow_downUnderstanding the EU Cosmetics Regulation and attaining compliance

It has been almost three years since the EU Cosmetics Regulation was put in force across Europe, replacing the preceding EU Cosmetics Directive. It is evident that it has become a real challenge for the cosmetics industry - even global brand leaders - to meet the robust regulatory requirements of the regulations. Even now, we are witnessing many providers of cosmetics products supplying products that do not fulfil all of the robust regulatory requirements of the cosmetic regulation.

keyboard_arrow_upRotoflex Security Series brings advancements in stringent label inspection
keyboard_arrow_downRotoflex Security Series brings advancements in stringent label inspection

Rotoflex has released the new Security Series for stringent label inspection and finishing. The fully integrated modules seamlessly integrate into the Rotoflex VSI, HSI and VLI product lines, either as a new equipment option or as a retrofit to existing installations.

keyboard_arrow_upYour waste, your responsibility
keyboard_arrow_downYour waste, your responsibility

Coschem held a lecture evening on 22 July 2015 on the topic of Hazardous waste management in South Africa. The talk outlined the steps cosmetics manufacturers should take to ensure they comply with legislation surrounding the responsible management of their waste streams.

keyboard_arrow_upOffline coding a solution to FMD compliance
keyboard_arrow_downOffline coding a solution to FMD compliance

Pyrotec PackMark recently reminded pharmaceutical manufacturers who sell their products on the European market about the Falsified Medicines Directive (FMD). Producers will have to comply with this legislation from January 2016.

keyboard_arrow_upCosmetics IQ launches interactive global guide on compliance
keyboard_arrow_downCosmetics IQ launches interactive global guide on compliance

The second Global Cosmetic Compliance Summit will bring together more than 70 directors of regulatory affairs, heads of compliance and brand owners from an international audience to tackle regulatory challenges across the globe and exploit growth in emerging and existing markets.

keyboard_arrow_upThe dti’s draft IP policy and the pharmaceutical industry
keyboard_arrow_downThe dti’s draft IP policy and the pharmaceutical industry

In the wake of the Department of Trade and Industry’s draft IP policy, Janusz Luterek, patent attorney and director of Hahn & Hahn, sheds light on the current patent law framework in South Africa and the impact the draft policy may have on the pharmaceutical industry should it eventually come into effect.